322.0K XNAS Volume
XNAS 21 Mar, 2025 3:01 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Todd C. Girolamo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 650,000 | 650,000 | - | - | Employee stock option (right to buy) | |
| Darin J. Weber | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 450,000 | 450,000 | - | - | Employee stock option (right to buy) | |
| James Coulston | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 650,000 | 650,000 | - | - | Employee stock option (right to buy) | |
| Bruce Culleton | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 1,796,000 | 1,796,000 | - | - | Employee stock option (right to buy) | |
| Brian J.G. Pereira | Director | 04 Feb 2025 | 81,928 | 81,928 | - | 0 | Class A Ordinary Shares | ||
| Brian J.G. Pereira | Director | 04 Feb 2025 | 675,234 | 675,234 | - | 0 | Class A Ordinary Shares | ||
| Brian J.G. Pereira | Director | 04 Feb 2025 | 81,928 | 81,929 | - | - | Class B Ordinary Shares | ||
| Brian J.G. Pereira | Director | 04 Feb 2025 | 81,928 | 81,929 | - | - | Common Units in ProKidney LP | ||
| Brian J.G. Pereira | Director | 04 Feb 2025 | 675,234 | 675,235 | - | - | Class B Ordinary Shares | ||
| Brian J.G. Pereira | Director | 04 Feb 2025 | 675,234 | 675,235 | - | - | Common Units in ProKidney LP | ||
| Pablo Legorreta | Director, Ten Percent Owner | 04 Feb 2025 | 532,535 | 23,150,444 | - | 0 | Class A Ordinary Shares | ||
| Pablo Legorreta | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 04 Feb 2025 | 532,535 | 22,617,909 | - | 0 | Class A Ordinary Shares | |
| Pablo Legorreta | Director, Ten Percent Owner | 04 Feb 2025 | 532,535 | 88,107,426 | - | - | Class B Ordinary Shares | ||
| Pablo Legorreta | Director, Ten Percent Owner | 04 Feb 2025 | 532,535 | 88,107,426 | - | - | Common Units in ProKidney LP | ||
| Darin J. Weber | Chief Regulatory Officer | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 19 Sep 2024 | 16,412 | 103,480 | - | 2.5 | 41,030 | Class A Ordinary Shares |
| Bruce Culleton | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2024 | 500,000 | 500,000 | - | - | Employee stock option (right to buy) | |
| Jennifer A. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 9,535 | 9,535 | - | - | Director stock option (right to buy) | |
| Todd C. Girolamo | Chief Legal Officer | 31 Jul 2024 | 81,928 | 163,857 | - | - | Common Units in ProKidney LP | ||
| Todd C. Girolamo | Chief Legal Officer | 31 Jul 2024 | 81,928 | 163,857 | - | - | Class B Ordinary Shares | ||
| Todd C. Girolamo | Chief Legal Officer | 31 Jul 2024 | 81,928 | 163,856 | - | 0 | Class A Ordinary Shares | ||
| Darin J. Weber | Chief Regulatory Officer | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 26 Jul 2024 | 826 | 119,892 | - | 2.5 | 2,065 | Class A Ordinary Shares |
| Darin J. Weber | Chief Regulatory Officer | Sale of securities on an exchange or to another person at price $ 2.82 per share. | 18 Jun 2024 | 17,238 | 120,718 | - | 2.8 | 48,616 | Class A Ordinary Shares |
| Pablo Legorreta | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.42 per share. | 13 Jun 2024 | 22,617,909 | 22,617,909 | - | 2.4 | 54,735,340 | Class A Ordinary Shares |
| Brian J.G. Pereira | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 62,558 | 62,558 | - | - | Director stock option (right to buy) | |
| William F. Doyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 62,558 | 62,558 | - | - | Director stock option (right to buy) | |
| Alan M. Lotvin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 62,558 | 62,558 | - | - | Director stock option (right to buy) | |
| Uma Sinha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 62,558 | 62,558 | - | - | Director stock option (right to buy) | |
| Pablo Legorreta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 62,558 | 62,558 | - | - | Director stock option (right to buy) | |
| Jennifer A. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 62,558 | 62,558 | - | - | Director stock option (right to buy) | |
| Jose Ignacio Jimenez Santos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 62,558 | 62,558 | - | - | Director stock option (right to buy) | |
| Darin J. Weber | Chief Regulatory Officer | Sale of securities on an exchange or to another person at price $ 4.08 per share. | 20 May 2024 | 17,238 | 137,956 | - | 4.1 | 70,386 | Class A Ordinary Shares |
| Darin J. Weber | SVP of Regulatory Development | Sale of securities on an exchange or to another person at price $ 2.51 per share. | 18 Apr 2024 | 16,438 | 155,194 | - | 2.5 | 41,315 | Class A Ordinary Shares |
| Darin J. Weber | SVP of Regulatory Development | Sale of securities on an exchange or to another person at price $ 2.54 per share. | 18 Apr 2024 | 800 | 171,632 | - | 2.5 | 2,028 | Class A Ordinary Shares |
| Darin J. Weber | SVP of Regulatory Development | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 16 Apr 2024 | 17,238 | 172,432 | - | 2.5 | 43,095 | Class A Ordinary Shares |
| Ulrich Ernst | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 335,000 | 335,000 | - | - | Employee stock option (right to buy) | |
| Darin J. Weber | SVP of Regulatory Development | Sale of securities on an exchange or to another person at price $ 1.69 per share. | 01 Apr 2024 | 300 | 273,773 | - | 1.7 | 507 | Class A Ordinary Shares |
| Darin J. Weber | SVP of Regulatory Development | Sale of securities on an exchange or to another person at price $ 1.73 per share. | 01 Apr 2024 | 84,103 | 189,670 | - | 1.7 | 145,498 | Class A Ordinary Shares |
| Todd C. Girolamo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 234,742 | 234,742 | - | - | Employee stock option (right to buy) | |
| Todd C. Girolamo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 300,000 | 300,000 | - | - | Employee stock option (right to buy) | |
| Darin Weber | SVP of Regulatory Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 225,000 | 225,000 | - | - | Employee stock option (right to buy) | |
| Darin Weber | SVP of Regulatory Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 117,264 | 117,264 | - | - | Employee stock option (right to buy) | |
| James Coulston | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 275,000 | 275,000 | - | - | Employee stock option (right to buy) | |
| Legorreta Pablo | Director, Ten Percent Owner | 05 Feb 2024 | 748,952 | 88,639,961 | - | - | Class B Ordinary Shares | ||
| Weber Darin | SVP of Regulatory Development | 05 Feb 2024 | 137,073 | 402,283 | - | - | Common Units in ProKidney LP | ||
| Darin Weber | SVP of Regulatory Development | 05 Feb 2024 | 137,073 | 274,073 | - | 0 | Class A Ordinary Shares | ||
| C. Girolamo Todd | Chief Legal Officer | 05 Feb 2024 | 81,928 | 81,928 | - | 0 | Class A Ordinary Shares | ||
| Darin Weber | SVP of Regulatory Development | 05 Feb 2024 | 137,073 | 402,283 | - | - | Class B Ordinary Shares | ||
| Pablo Legorreta | Director, Ten Percent Owner | 05 Feb 2024 | 748,952 | 88,639,961 | - | - | Common Units in ProKidney LP | ||
| Todd Girolamo C. | Chief Legal Officer | 05 Feb 2024 | 81,928 | 245,785 | - | - | Common Units in ProKidney LP | ||
| Pablo Legorreta | Director, Ten Percent Owner | 05 Feb 2024 | 748,952 | 748,952 | - | 0 | Class A Ordinary Shares | ||
| Legorreta Pablo | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 05 Feb 2024 | 748,952 | 0 | - | 0 | Class A Ordinary Shares | |
| Todd Girolamo C. | Chief Legal Officer | 05 Feb 2024 | 81,928 | 245,785 | - | - | Class B Ordinary Shares | ||
| Culleton Bruce | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2023 | 2,000,000 | 2,000,000 | - | - | Employee stock option (right to buy) | |
| Darin Weber | SVP of Regulatory Development | 25 Aug 2023 | 137,000 | 137,000 | - | 0 | Class A Ordinary Shares | ||
| Darin Weber | SVP of Regulatory Development | 25 Aug 2023 | 137,000 | 539,356 | - | - | Common Units in ProKidney LP | ||
| Darin Weber | SVP of Regulatory Development | 25 Aug 2023 | 137,000 | 539,356 | - | - | Class B Ordinary Shares | ||
| Bruce Culleton | EVP, Clinical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 485,000 | 485,000 | - | - | Employee stock option (right to buy) | |
| Jennifer A. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2023 | 46,632 | 46,632 | - | - | Director stock option (right to buy) | |
| Jennifer A. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2023 | 42,515 | 42,515 | - | - | Director stock option (right to buy) | |
| Brian J.G. Pereira | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 48,128 | 48,128 | - | - | Director stock option (right to buy) | |
| John M. Maraganore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 48,128 | 48,128 | - | - | Director stock option (right to buy) | |
| William F. Doyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 48,128 | 48,128 | - | - | Director Stock Option (right to buy) | |
| Alan M. Lotvin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 48,128 | 48,128 | - | - | Director stock option (right to buy) | |
| Uma Sinha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 48,128 | 48,128 | - | - | Director stock option (right to buy) | |
| Pablo Legorreta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 48,128 | 48,128 | - | - | Director stock option (right to buy) | |
| Jose Ignacio Jimenez Santos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 48,128 | 48,128 | - | - | Director stock option (right to buy) | |
| Timothy Bertram | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2023 | 1,011,500 | 1,011,500 | - | - | Employee stock option (right to buy) | |
| Deepak Jain | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2023 | 585,000 | 585,000 | - | - | Employee stock option (right to buy) | |
| Todd C. Girolamo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2023 | 290,000 | 290,000 | - | - | Employee stock option (right to buy) | |
| Darin Weber | SVP of Regulatory Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2023 | 250,000 | 250,000 | - | - | Employee stock option (right to buy) | |
| James Coulston | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2023 | 290,000 | 290,000 | - | - | Employee stock option, right to buy | |
| Libbie P. McKenzie | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2023 | 250,000 | 250,000 | - | - | Employee stock option (right to buy) | |
| Timothy Bertram | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2022 | 3,639,607 | 3,639,607 | - | - | Employee stock option (right to buy) | |
| Deepak Jain | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2022 | 929,507 | 929,507 | - | - | Employee stock option (right to buy) | |
| Todd C. Girolamo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2022 | 696,793 | 696,793 | - | - | Employee stock option (right to buy) | |
| Darin Weber | SVP of Regulatory Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2022 | 418,076 | 418,076 | - | - | Employee stock option (right to buy) | |
| James Coulston | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2022 | 325,170 | 325,170 | - | - | Employee stock option (right to buy) | |
| Libbie P. McKenzie | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2022 | 696,793 | 696,793 | - | - | Employee stock option (right to buy) | |
| Jennifer A. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2022 | 129,370 | 129,370 | - | - | Stock option (right to buy) | |
| Brian J.G. Pereira | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 1,514,326 | 1,514,326 | - | - | Class B Ordinary Shares | |
| Brian J.G. Pereira | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 1,514,326 | 1,514,326 | - | - | Common Units in ProKidney LP | |
| John M. Maraganore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 614,013 | 614,013 | - | - | Common Units in ProKidney LP | |
| John M. Maraganore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 614,013 | 614,013 | - | - | Class B Ordinary Shares | |
| William F. Doyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 1,514,326 | 1,514,326 | - | - | Class B Ordinary Shares | |
| William F. Doyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 1,514,326 | 1,514,326 | - | - | Common Units in ProKidney LP | |
| Alan M. Lotvin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 1,514,326 | 1,514,326 | - | - | Common Units in ProKidney LP | |
| Alan M. Lotvin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 1,514,326 | 1,514,326 | - | - | Class B Ordinary Shares | |
| Timothy Bertram | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 4,944,938 | 4,944,938 | - | - | Common Units in ProKidney LP | |
| Timothy Bertram | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 4,944,938 | 4,944,938 | - | - | Class B Ordinary Shares | |
| Deepak Jain | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 1,567,939 | 1,567,939 | - | - | Common Units in ProKidney LP | |
| Deepak Jain | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 1,567,939 | 1,567,939 | - | - | Class B Ordinary Shares | |
| Uma Sinha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 30,000 | 30,000 | - | 0 | Class A Ordinary Shares | |
| Todd C. Girolamo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 327,713 | 327,713 | - | - | Common Units in ProKidney LP | |
| Todd C. Girolamo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 327,713 | 327,713 | - | - | Class B Ordinary Shares | |
| Darin Weber | SVP of Regulatory Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 676,356 | 676,356 | - | - | Common Units in ProKidney LP | |
| Darin Weber | SVP of Regulatory Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 676,356 | 676,356 | - | - | Class B Ordinary Shares | |
| Pablo Legorreta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 94,677,968 | 94,677,968 | - | - | Common Units in ProKidney LP | |
| Pablo Legorreta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 94,677,968 | 94,677,968 | - | - | Class B Ordinary Shares | |
| Pablo Legorreta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 10,500,000 | 10,500,000 | - | - | Earnout Rights | |
| James Coulston | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 716,850 | 716,850 | - | - | Class B Ordinary Shares | |
| James Coulston | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 716,850 | 716,850 | - | - | Common Units in ProKidney LP | |
| Libbie P. McKenzie | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 327,713 | 327,713 | - | - | Common Units in ProKidney LP | |
| Libbie P. McKenzie | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 327,713 | 327,713 | - | - | Class B Ordinary Shares |